Aurinia Pharmaceuticals Stock Price History
| AUPH Stock | USD 8.98 0.03 0.34% |
Below is the normalized historical share price chart for Aurinia Pharmaceuticals extending back to July 16, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Aurinia Pharmaceuticals stands at 8.98, as last reported on the 26th of December, with the highest price reaching 9.01 and the lowest price hitting 8.90 during the day.
If you're considering investing in Aurinia Stock, it is important to understand the factors that can impact its price. Aurinia Pharmaceuticals appears to be somewhat reliable, given 3 months investment horizon. Aurinia Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.12, which signifies that the company had a 0.12% return per unit of risk over the last 3 months. We have found thirty technical indicators for Aurinia Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please makes use of Aurinia Pharmaceuticals' Risk Adjusted Performance of 0.1209, downside deviation of 2.09, and Mean Deviation of 1.98 to double-check if our risk estimates are consistent with your expectations.
As of now, Aurinia Pharmaceuticals' Common Stock Total Equity is increasing as compared to previous years. The Aurinia Pharmaceuticals' current Common Stock is estimated to increase to about 1.3 B, while Other Stockholder Equity is projected to decrease to under 66.4 M. . As of now, Aurinia Pharmaceuticals' Price Fair Value is increasing as compared to previous years. Aurinia Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of January 1999 | 200 Day MA 6.3834 | 50 Day MA 8.2724 | Beta 1.456 |
Aurinia |
Sharpe Ratio = 0.1241
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AUPH | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.04 actual daily | 27 73% of assets are more volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Aurinia Pharmaceuticals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aurinia Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 3.3138 | Enterprise Value Ebitda 233.4519 | Price Sales 5.8347 | Shares Float 128.9 M | Wall Street Target Price 10.8357 |
Aurinia Pharmaceuticals Stock Price History Chart
There are several ways to analyze Aurinia Stock price data. The simplest method is using a basic Aurinia candlestick price chart, which shows Aurinia Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | December 10, 2024 | 10.44 |
| Lowest Price | October 9, 2024 | 6.75 |
Aurinia Pharmaceuticals December 26, 2024 Stock Price Synopsis
Various analyses of Aurinia Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Aurinia Stock. It can be used to describe the percentage change in the price of Aurinia Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Aurinia Stock.| Aurinia Pharmaceuticals Price Rate Of Daily Change | 1.00 | |
| Aurinia Pharmaceuticals Price Action Indicator | 0.04 | |
| Aurinia Pharmaceuticals Price Daily Balance Of Power | 0.27 |
Aurinia Pharmaceuticals December 26, 2024 Stock Price Analysis
Aurinia Stock Price History Data
The price series of Aurinia Pharmaceuticals for the period between Fri, Sep 27, 2024 and Thu, Dec 26, 2024 has a statistical range of 3.69 with a coefficient of variation of 12.07. The prices are distributed with arithmetic mean of 8.01. The median price for the last 90 days is 8.01. The company had 1:50 stock split on 23rd of October 2013.| Open | High | Low | Close | Volume | ||
12/26/2024 | 8.99 | 9.01 | 8.90 | 8.98 | ||
| 12/24/2024 | 8.99 | 9.01 | 8.90 | 8.98 | 487,429 | |
| 12/23/2024 | 9.02 | 9.05 | 8.93 | 8.95 | 931,332 | |
| 12/20/2024 | 8.95 | 9.23 | 8.92 | 9.03 | 1,409,769 | |
| 12/19/2024 | 9.15 | 9.21 | 8.92 | 9.04 | 1,118,419 | |
| 12/18/2024 | 9.57 | 9.60 | 8.97 | 9.10 | 1,184,700 | |
| 12/17/2024 | 9.58 | 9.76 | 9.40 | 9.55 | 1,275,313 | |
| 12/16/2024 | 9.37 | 9.66 | 9.26 | 9.63 | 1,090,000 | |
| 12/13/2024 | 9.65 | 9.69 | 9.22 | 9.37 | 1,278,807 | |
| 12/12/2024 | 10.05 | 10.15 | 9.68 | 9.69 | 1,352,760 | |
| 12/11/2024 | 10.45 | 10.48 | 9.98 | 10.11 | 2,085,463 | |
| 12/10/2024 | 9.50 | 10.67 | 9.43 | 10.44 | 4,634,763 | |
| 12/09/2024 | 8.94 | 9.19 | 8.87 | 9.13 | 1,660,784 | |
| 12/06/2024 | 8.85 | 9.15 | 8.84 | 8.93 | 1,173,254 | |
| 12/05/2024 | 8.71 | 8.99 | 8.71 | 8.88 | 1,179,998 | |
| 12/04/2024 | 8.85 | 8.91 | 8.71 | 8.72 | 847,269 | |
| 12/03/2024 | 9.10 | 9.17 | 8.82 | 8.85 | 1,329,200 | |
| 12/02/2024 | 8.85 | 9.24 | 8.76 | 9.10 | 2,324,900 | |
| 11/29/2024 | 8.85 | 9.02 | 8.77 | 8.86 | 769,323 | |
| 11/27/2024 | 8.75 | 8.91 | 8.70 | 8.85 | 1,215,698 | |
| 11/26/2024 | 8.70 | 8.78 | 8.65 | 8.71 | 750,600 | |
| 11/25/2024 | 8.94 | 8.99 | 8.69 | 8.71 | 1,535,066 | |
| 11/22/2024 | 8.75 | 9.04 | 8.65 | 8.86 | 1,562,963 | |
| 11/21/2024 | 8.31 | 8.83 | 8.30 | 8.77 | 2,406,360 | |
| 11/20/2024 | 8.07 | 8.26 | 7.91 | 8.24 | 1,273,531 | |
| 11/19/2024 | 7.95 | 8.14 | 7.89 | 8.13 | 1,246,728 | |
| 11/18/2024 | 8.13 | 8.14 | 7.87 | 8.01 | 1,172,293 | |
| 11/15/2024 | 8.36 | 8.39 | 8.07 | 8.12 | 1,415,187 | |
| 11/14/2024 | 8.33 | 8.41 | 8.10 | 8.33 | 1,360,366 | |
| 11/13/2024 | 8.43 | 8.48 | 8.06 | 8.28 | 1,557,461 | |
| 11/12/2024 | 8.46 | 8.58 | 8.28 | 8.38 | 1,550,889 | |
| 11/11/2024 | 8.29 | 8.70 | 8.29 | 8.49 | 1,929,409 | |
| 11/08/2024 | 8.39 | 8.39 | 7.98 | 8.32 | 2,193,543 | |
| 11/07/2024 | 7.84 | 8.74 | 7.80 | 8.34 | 4,243,015 | |
| 11/06/2024 | 7.45 | 7.56 | 7.33 | 7.52 | 1,596,101 | |
| 11/05/2024 | 7.17 | 7.35 | 7.10 | 7.32 | 948,538 | |
| 11/04/2024 | 7.28 | 7.28 | 7.03 | 7.21 | 1,196,667 | |
| 11/01/2024 | 7.19 | 7.37 | 7.16 | 7.32 | 820,927 | |
| 10/31/2024 | 7.37 | 7.39 | 7.21 | 7.21 | 825,180 | |
| 10/30/2024 | 7.48 | 7.48 | 7.33 | 7.36 | 876,847 | |
| 10/29/2024 | 7.21 | 7.50 | 7.18 | 7.49 | 1,036,818 | |
| 10/28/2024 | 7.12 | 7.32 | 7.09 | 7.24 | 1,063,222 | |
| 10/25/2024 | 7.05 | 7.18 | 7.00 | 7.05 | 795,571 | |
| 10/24/2024 | 7.02 | 7.08 | 6.94 | 7.04 | 604,217 | |
| 10/23/2024 | 7.04 | 7.05 | 6.85 | 6.99 | 783,937 | |
| 10/22/2024 | 7.13 | 7.15 | 7.00 | 7.07 | 489,807 | |
| 10/21/2024 | 7.03 | 7.20 | 6.94 | 7.17 | 1,019,600 | |
| 10/18/2024 | 7.20 | 7.23 | 6.95 | 7.03 | 1,077,773 | |
| 10/17/2024 | 7.16 | 7.30 | 7.13 | 7.18 | 701,400 | |
| 10/16/2024 | 7.26 | 7.33 | 7.17 | 7.18 | 682,741 | |
| 10/15/2024 | 7.13 | 7.25 | 7.09 | 7.20 | 770,069 | |
| 10/14/2024 | 7.11 | 7.13 | 6.99 | 7.12 | 521,409 | |
| 10/11/2024 | 7.00 | 7.11 | 6.92 | 7.08 | 895,140 | |
| 10/10/2024 | 6.68 | 6.98 | 6.64 | 6.98 | 962,355 | |
| 10/09/2024 | 6.83 | 6.83 | 6.71 | 6.75 | 699,616 | |
| 10/08/2024 | 6.82 | 6.92 | 6.76 | 6.82 | 502,047 | |
| 10/07/2024 | 7.09 | 7.14 | 6.83 | 6.84 | 604,918 | |
| 10/04/2024 | 7.08 | 7.16 | 6.99 | 7.12 | 791,935 | |
| 10/03/2024 | 7.04 | 7.12 | 6.91 | 7.02 | 1,048,460 | |
| 10/02/2024 | 7.22 | 7.31 | 7.04 | 7.12 | 1,143,637 | |
| 10/01/2024 | 7.30 | 7.34 | 7.11 | 7.26 | 873,187 |
About Aurinia Pharmaceuticals Stock history
Aurinia Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Aurinia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Aurinia Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Aurinia Pharmaceuticals stock prices may prove useful in developing a viable investing in Aurinia Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 143.2 M | 150.4 M | |
| Net Loss | -97.4 M | -92.5 M |
Aurinia Pharmaceuticals Quarterly Net Working Capital |
|
Aurinia Pharmaceuticals Stock Technical Analysis
Aurinia Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Cryptocurrency Center Now
Cryptocurrency CenterBuild and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
| All Next | Launch Module |
Aurinia Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Aurinia Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Aurinia Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Aurinia to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1209 | |||
| Jensen Alpha | 0.3866 | |||
| Total Risk Alpha | 0.2848 | |||
| Sortino Ratio | 0.1817 | |||
| Treynor Ratio | 0.5145 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Aurinia Stock analysis
When running Aurinia Pharmaceuticals' price analysis, check to measure Aurinia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurinia Pharmaceuticals is operating at the current time. Most of Aurinia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aurinia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurinia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aurinia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets |